|
|
|
|
A project coordinated by VTT turns plant cells into medical factories |
|
|
VTT Technical Research Centre of Finland will coordinate the large EU research project called SmartCell. The four-year project focuses on developing methods for production of valuable pharmaceutical compounds using plant cells as a production host in an effective and controlled manner. The methods based on plant biotechnology are an alternative to chemical synthesis. By controlling the cell metabolism of a 'green factory', i.e. a living plant cell, it is possible to affect the production of desired high-value compounds. This kind of metabolic engineering also stimulates the cells towards producing completely new compounds.
|
|
|
|
|
|
Novo Nordisk acquires intellectual property rights from Neose Technologies |
|
|
Novo Nordisk today announced that it has signed an agreement to acquire intellectual property rights from Neose Technologies Inc. related to Neose's proprietary GlycoPEGylation technology. The acquired rights are currently subject to a license from Neose for Novo Nordisk's development of GlycoPEGylated recombinant blood clotting factors FVIIa, FVIII and FIX.
|
|
|
|
|
|
News